nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HRH3—narcolepsy	0.749	0.814	CbGaD
Donepezil—HTR2A—narcolepsy	0.171	0.186	CbGaD
Donepezil—HTR2A—enteric nervous system—narcolepsy	0.00975	0.217	CbGeAlD
Donepezil—HTR2A—locus ceruleus—narcolepsy	0.00644	0.143	CbGeAlD
Donepezil—HRH3—brainstem—narcolepsy	0.00427	0.095	CbGeAlD
Donepezil—HRH3—forebrain—narcolepsy	0.00412	0.0917	CbGeAlD
Donepezil—HTR2A—pons—narcolepsy	0.00371	0.0825	CbGeAlD
Donepezil—ACHE—Synthesis of PC—CHKB—narcolepsy	0.00358	0.102	CbGpPWpGaD
Donepezil—HTR2A—autonomic nervous system—narcolepsy	0.00342	0.0761	CbGeAlD
Donepezil—HRH3—brain—narcolepsy	0.00171	0.038	CbGeAlD
Donepezil—ACHE—medulla oblongata—narcolepsy	0.00161	0.0358	CbGeAlD
Donepezil—ACHE—midbrain—narcolepsy	0.00147	0.0328	CbGeAlD
Donepezil—ACHE—Monoamine Transport—HRH3—narcolepsy	0.00113	0.0322	CbGpPWpGaD
Donepezil—SIGMAR1—medulla oblongata—narcolepsy	0.00108	0.024	CbGeAlD
Donepezil—ACHE—Glycerophospholipid biosynthesis—CHKB—narcolepsy	0.00105	0.0298	CbGpPWpGaD
Donepezil—SIGMAR1—midbrain—narcolepsy	0.000988	0.022	CbGeAlD
Donepezil—HRH3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000969	0.0275	CbGpPWpGaD
Donepezil—ACHE—brain—narcolepsy	0.000926	0.0206	CbGeAlD
Donepezil—HTR2A—brainstem—narcolepsy	0.000826	0.0184	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000818	0.0232	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000818	0.0232	CbGpPWpGaD
Donepezil—HTR2A—forebrain—narcolepsy	0.000797	0.0177	CbGeAlD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00079	0.0224	CbGpPWpGaD
Donepezil—CYP2D6—brainstem—narcolepsy	0.000753	0.0167	CbGeAlD
Donepezil—ACHE—Phospholipid metabolism—CHKB—narcolepsy	0.000733	0.0208	CbGpPWpGaD
Donepezil—CYP2D6—forebrain—narcolepsy	0.000727	0.0162	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0007	0.0199	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0007	0.0199	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000677	0.0192	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—PENK—narcolepsy	0.000645	0.0183	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—HRH3—narcolepsy	0.000643	0.0183	CbGpPWpGaD
Donepezil—SIGMAR1—brain—narcolepsy	0.000621	0.0138	CbGeAlD
Donepezil—HTR2A—GPCRs, Other—P2RY11—narcolepsy	0.000602	0.0171	CbGpPWpGaD
Donepezil—HTR2A—medulla oblongata—narcolepsy	0.000576	0.0128	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000575	0.0163	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HCRTR1—narcolepsy	0.000533	0.0152	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HCRTR2—narcolepsy	0.000533	0.0152	CbGpPWpGaD
Donepezil—HTR2A—midbrain—narcolepsy	0.000527	0.0117	CbGeAlD
Donepezil—HRH3—GPCR ligand binding—P2RY11—narcolepsy	0.000515	0.0146	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000513	0.0146	CbGpPWpGaD
Donepezil—HRH3—Monoamine Transport—TNF—narcolepsy	0.000508	0.0144	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HCRT—narcolepsy	0.000438	0.0124	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000436	0.0124	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—PENK—narcolepsy	0.00039	0.0111	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00035	0.00995	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00035	0.00995	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—P2RY11—narcolepsy	0.000338	0.00961	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—TRH—narcolepsy	0.000332	0.00943	CbGpPWpGaD
Donepezil—HTR2A—brain—narcolepsy	0.000331	0.00736	CbGeAlD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000317	0.009	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000317	0.009	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000313	0.0089	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000313	0.0089	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000302	0.00859	CbGpPWpGaD
Donepezil—CYP2D6—brain—narcolepsy	0.000301	0.0067	CbGeAlD
Donepezil—HRH3—GPCR downstream signaling—HCRTR2—narcolepsy	0.000301	0.00856	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HCRTR1—narcolepsy	0.000301	0.00856	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—P2RY11—narcolepsy	0.000291	0.00827	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—HCRT—narcolepsy	0.000288	0.00817	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HCRTR2—narcolepsy	0.000274	0.00778	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HCRTR1—narcolepsy	0.000274	0.00778	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000271	0.00769	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000271	0.00769	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—P2RY11—narcolepsy	0.000264	0.00751	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000261	0.00743	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000257	0.00731	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HCRT—narcolepsy	0.000248	0.00703	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—TNF—narcolepsy	0.000243	0.00691	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—TAC1—narcolepsy	0.000241	0.00685	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—NPS—narcolepsy	0.000241	0.00685	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000236	0.00671	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000232	0.00659	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000232	0.00659	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HCRT—narcolepsy	0.000225	0.00639	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000224	0.00636	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000222	0.00632	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PENK—narcolepsy	0.000221	0.00627	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—TRH—narcolepsy	0.000218	0.00619	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PENK—narcolepsy	0.0002	0.00569	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000195	0.00554	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000191	0.00541	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00019	0.00541	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—TRH—narcolepsy	0.000188	0.00533	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000183	0.0052	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000177	0.00502	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000177	0.00502	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000171	0.00485	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—TRH—narcolepsy	0.00017	0.00484	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00017	0.00482	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HCRTR1—narcolepsy	0.000162	0.00459	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HCRTR2—narcolepsy	0.000162	0.00459	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00016	0.00456	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000158	0.0045	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000158	0.0045	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—P2RY11—narcolepsy	0.000156	0.00444	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000148	0.0042	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—HTR2A—narcolepsy	0.000145	0.00412	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000145	0.00412	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000144	0.0041	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000142	0.00402	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000142	0.00402	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—TAC1—narcolepsy	0.000136	0.00387	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—NPS—narcolepsy	0.000136	0.00387	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HCRT—narcolepsy	0.000133	0.00377	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000129	0.00367	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000127	0.0036	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—TAC1—narcolepsy	0.000124	0.00352	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—NPS—narcolepsy	0.000124	0.00352	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PENK—narcolepsy	0.000118	0.00336	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.00011	0.00312	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CHKB—narcolepsy	0.000105	0.00299	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000105	0.00298	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000105	0.00298	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TRH—narcolepsy	0.000101	0.00286	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	9.98e-05	0.00284	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	9.98e-05	0.00284	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	9.64e-05	0.00274	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—HRH3—narcolepsy	9.64e-05	0.00274	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	9.6e-05	0.00273	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	9.06e-05	0.00257	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	9.06e-05	0.00257	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	8.75e-05	0.00249	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—HTR2A—narcolepsy	8.2e-05	0.00233	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	8.2e-05	0.00233	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—TAC1—narcolepsy	7.99e-05	0.00227	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—NPS—narcolepsy	7.99e-05	0.00227	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HTR2A—narcolepsy	7.45e-05	0.00212	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HCRT—narcolepsy	7.44e-05	0.00211	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NPS—narcolepsy	7.31e-05	0.00208	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TAC1—narcolepsy	7.31e-05	0.00208	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PENK—narcolepsy	7.3e-05	0.00208	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CPT1B—narcolepsy	7.14e-05	0.00203	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PENK—narcolepsy	6.63e-05	0.00188	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	6.52e-05	0.00185	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—TRH—narcolepsy	6.21e-05	0.00176	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	5.82e-05	0.00165	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TRH—narcolepsy	5.64e-05	0.0016	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	5.45e-05	0.00155	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	5.35e-05	0.00152	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	5.35e-05	0.00152	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—P2RY11—narcolepsy	5.17e-05	0.00147	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRH3—narcolepsy	4.95e-05	0.00141	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	4.74e-05	0.00135	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—NPS—narcolepsy	4.51e-05	0.00128	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	4.51e-05	0.00128	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HTR2A—narcolepsy	4.4e-05	0.00125	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HCRT—narcolepsy	4.4e-05	0.00125	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CHKB—narcolepsy	4.31e-05	0.00122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CHKB—narcolepsy	4.27e-05	0.00121	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NPS—narcolepsy	4.1e-05	0.00116	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TAC1—narcolepsy	4.1e-05	0.00116	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PENK—narcolepsy	3.92e-05	0.00111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TRH—narcolepsy	3.33e-05	0.000947	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CPT1B—narcolepsy	2.93e-05	0.000833	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRH3—narcolepsy	2.92e-05	0.00083	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CPT1B—narcolepsy	2.91e-05	0.000825	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CHKB—narcolepsy	2.82e-05	0.000801	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TAC1—narcolepsy	2.42e-05	0.000688	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NPS—narcolepsy	2.42e-05	0.000688	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CPT1B—narcolepsy	1.92e-05	0.000544	CbGpPWpGaD
